Skip to content

Improving In-hospital Stroke Service Utilisation in China

Improving In-hospital Stroke Service Utilisation (MISSION) in China: A Cluster Randomised Trial of Interventions to Shorten Door to Needle Times

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03317639
Enrollment
1634
Registered
2017-10-23
Start date
2018-01-01
Completion date
2020-06-30
Last updated
2021-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke, Door to Treatment Time, Quality Improvement, Thrombolytic Therapy

Brief summary

A cluster randomised controlled trial will be conducted, using hospital as randomisation unit. Hospitals in Zhejiang Province, China, will be randomised into two arms (1:1): an intervention arm and a control arm. Hospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model, whereas hospitals in the control arm will receive no intervention and maintain existing care. The randomisation will be conducted after one-year baseline data collection. The following baseline data will be used for randomisation match: hospital classification, beds in stroke centre, thrombolysis patient number, and percentage of patients receiving thrombolysis within 60 minutes of stroke onset. Hospitals with no stroke centre or with \<20 cases received thrombolysis per year will be excluded from the study. The primary outcome will be difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage (post-intervention).

Interventions

BEHAVIORALBehaviour Change Wheel model guided intervention

Interventions are developed on a psychological model, the Behaviour Change Wheel (BCW) .The fundamental of BCW consists of three essential elements: capability, motivation, and opportunity. Improving individual's capability, providing motivation, and increasing opportunities are goals of behaviour change intervention. To achieve the goals, 9 intervention components have been proposed in the BCW framework, and 6 components will be used in current study.

Sponsors

Shaoxing Second Hospital
CollaboratorOTHER
Haining People' s Hospital
CollaboratorUNKNOWN
Haiyan People' s Hospital
CollaboratorUNKNOWN
Huzhou No.1 People' s Hospital
CollaboratorUNKNOWN
Jiashan No.1 People' s Hospital
CollaboratorUNKNOWN
Ningbo Medical Center Lihuili Hospital
CollaboratorOTHER_GOV
Tongxiang No.1 People' s Hospital
CollaboratorUNKNOWN
First Affiliated Hospital of Wenzhou Medical University
CollaboratorOTHER
Yiwu Central Hospital
CollaboratorOTHER
Yongkang No.1 People' s Hospital
CollaboratorUNKNOWN
Yuyao People's Hospital
CollaboratorOTHER
Deqing People' s Hospital
CollaboratorUNKNOWN
Dongyang People's Hospital
CollaboratorOTHER
Jinhua People' s Hospital
CollaboratorUNKNOWN
Lishui People' s Hospital
CollaboratorUNKNOWN
Lin' an People' s Hospital
CollaboratorUNKNOWN
Longquan People' s Hospital
CollaboratorUNKNOWN
Qingtian People' s Hospital
CollaboratorUNKNOWN
Shaoxing Central Hospital
CollaboratorOTHER
Wenzhou Central Hospital
CollaboratorOTHER
Xiangshan No.1 People' s Hospital
CollaboratorUNKNOWN
The Central Hospital of Lishui City
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* AIS patients receiving IVT within 4.5 hours

Exclusion criteria

* Patients who are not willing to attend this trial

Design outcomes

Primary

MeasureTime frameDescription
Difference in the percentage of patients who Door-to-Needle Time≤60minUp to 24 hoursDifference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage

Secondary

MeasureTime frameDescription
DeathUp to 3 monthDeath at discharge
Door-to-needle timeUp to 24 hoursThe time between hospital arrival and the initiation of IVT
Favorable neurological outcomesAt 90 daysScore of 0 to 1 on the modified Rankin Scale, on which scores range from 0 (no neurologic deficit) to 6 (death)
modified Rankin Scale score at dischargeUp to 3 monthmodified Rankin Scale score at discharge, on which scores range from 0 (no neurologic deficit) to 6 (death)
Symptomatic intracranial hemorrhageAt 24 hoursIntracranial hemorrhage at 24 hours associated with an increase of ≥4 points of NIHSS score from baseline, according to European Cooperative Acute Stroke Study (ECASS) II trial
Onset-to-needle timeUp to 24 hoursThe time between the symptom onset and the initiation of IVT

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026